Literature DB >> 25483817

MicroRNA-145 inhibits lung cancer cell metastasis.

Dong-Jin Ling1, Zhong-Shu Chen1, Yang-De Zhang1, Qian-De Liao2, Jian-Xiong Feng3, Xue-Yu Zhang3, Tian-Sheng Shi3.   

Abstract

Previous studies have identified a variety of microRNAs (miRNAs) that have important roles in cancer progression, particularly in tumor invasion and metastasis. Downregulation of miR‑145 was reported to occur in various types of human cancer; however, the role of miR‑145 in lung cancer metastasis and its potential mechanisms of action remain to be elucidated. The present study aimed to investigate the effects of miR‑145 on metastasis and epithelial‑mesenchymal transition (EMT) in A549 human lung adenocarcinoma cells. In addition, the underlying mechanisms by which miR‑145 regulates EMT were examined. The miR‑145 mimic was transfected into A549 cells; cell invasion and adhesion assays were then performed in order to investigate cell metastasis, and western blot analysis was used to examine the expression of EMT markers. In order to further examine the underlying mechanisms by which miR‑145 regulates EMT, a luciferase reporter assay was performed to determine whether miR‑145 targeted Oct4. In addition, the expression of Wnt3a and β‑catenin in A549 cells was measured following transfection with small hairpin RNA‑Oct4. To the best of our knowledge, the results of the present study demonstrated for the first time, that miR‑145 inhibited lung cancer cell metastasis and EMT via targeting the Oct4 mediated Wnt/β‑catenin signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25483817     DOI: 10.3892/mmr.2014.3036

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  Overexpression of microRNA-936 suppresses non-small cell lung cancer cell proliferation and invasion via targeting E2F2.

Authors:  Xiao Zhou; Hui Tao
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

2.  microRNA-664 enhances proliferation, migration and invasion of lung cancer cells.

Authors:  Xinhai Zhu; Sheng Ju; Feng Yuan; Guoping Chen; Yue Shu; Chuanchuan Li; Yanhui Xu; Jing Luo; Lilong Xia
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

3.  Overexpression of miR-1260b in Non-small Cell Lung Cancer is Associated with Lymph Node Metastasis.

Authors:  Limin Xu; Liqin Li; Jing Li; Hongwei Li; Qibin Shen; Jinliang Ping; Zhihong Ma; Jing Zhong; Licheng Dai
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

4.  LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.

Authors:  Junhua Luo; Jing Chen; Hang Li; Yu Yang; Haichao Yun; Shangqi Yang; Xiangming Mao
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

5.  Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer.

Authors:  Hu Wei; Chen Wen-Ming; Jiao Jun-Bo
Journal:  J Int Med Res       Date:  2017-05-23       Impact factor: 1.671

Review 6.  The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer.

Authors:  Yin Peng; Xiaojing Zhang; Xianling Feng; Xinmim Fan; Zhe Jin
Journal:  Oncotarget       Date:  2017-02-21

Review 7.  The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity.

Authors:  Ming-Xin Cao; Ya-Ping Jiang; Ya-Ling Tang; Xin-Hua Liang
Journal:  Oncotarget       Date:  2017-02-14

8.  Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.

Authors:  Shuang Wei; Zun-Yi Zhang; Sheng-Ling Fu; Jun-Gang Xie; Xian-Sheng Liu; Yong-Jian Xu; Jian-Ping Zhao; Wei-Ning Xiong
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

Review 9.  Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.

Authors:  Yunus A Luqmani; Nada Alam-Eldin
Journal:  Med Princ Pract       Date:  2016-02-05       Impact factor: 1.927

10.  miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade.

Authors:  Yi Pan; Conglin Ye; Qingshan Tian; Songxin Yan; Xiaoping Zeng; Chu Xiao; Lingyun Wang; Hongmei Wang
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.